Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China

This protocol was developed to conduct population-wide surveillance of the bivalent HPV-16/18-AS04-adjuvanted human papillomavirus (HPV) vaccine in terms of uptake and safety outcomes including potential immune-mediated diseases (pIMDs) and pregnancy-related outcomes in China. The study will use ele...

Повний опис

Бібліографічні деталі

Автори:	Junting Yang, Sarah Welby, Zhike Liu, Siwei Deng, Guangxu Liu, Ruogu Meng, Yu Yang, Yixin Sun, Yunkun He, Ning Jiang, Zhenhua Wu, Keruo Liu, Dominique Rosillon, Catherine Cohet, Siyan Zhan
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Taylor & Francis Group 2024-12-01
Серія:	Human Vaccines & Immunotherapeutics
Предмети:	HPV-16/18-AS04 human papillomavirus vaccine safety potential immune-mediated diseases pregnancy outcomes
Онлайн доступ:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2378535
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!